Zhejiang Anbeite Pharmaceutical Co., Ltd.

Main purpose: To observe the time course of blood drug concentration after a single oral dose of the test preparation rifampicin capsule (0.15g) in healthy subjects in the fasting state, and to estimate the corresponding pharmacokinetic parameters; and to conduct a formal bioequivalence test using rifampicin capsule (0.15g, Sanofi-Aventis US LLC, trade name: RIFADIN) as the reference preparation, to provide a reference for the consistency evaluation application and clinical application of the drug. Secondary purpose: To observe the safety of the test preparation and the reference preparation when the subjects take them orally in the fasting state.